TKTL1 and metabolic syndrome: We propose, that the protective capacity of the TKTL1-pathway is not sufficient to compete with a chronic glycaemic overload, a condition which favours the development of several civilization-related diseases like the Alzheimer disease, type 2 diabetes, and the metabolic syndrome.